GSA Capital Partners »

Acumen Pharmaceuticals shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $103k 25k 4.06

More positions owned by GSA Capital Partners

Progressive Corporation (PGR)
Amazon (AMZN)
Root Cl A New (ROOT)
Meta Platforms Cl A (META)
Monster Beverage Corp (MNST)
UGI Corporation (UGI)
Magnite Ord (MGNI)
John B. Sanfilippo & Son (JBSS)
Dt Midstream Common Stock (DTM)
Weis Markets (WMK)
Apa Corporation (APA)
Appfolio Com Cl A (APPF)
Hims & Hers Health Com Cl A (HIMS)
Zoetis Cl A (ZTS)
Vital Farms (VITL)

View all positions for GSA Capital Partners

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Sands Capital Ventures
Franklin Resources
Millennium Management
Rock Springs Capital Management
FMR
Laurion Capital Management
Vanguard Group
T. Rowe Price Associates
Alyeska Investment Group
Jane Street
Susquehanna International
Parkman Healthcare Partners
Hudson Bay Capital Management
Pathstone Holdings

View all funds holding Acumen Pharmaceuticals